Stay updated with breaking news from Lyfius Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Amaravati: The State Investment Promotion Board (SIPB) meeting held here on Monday under the Chairmanship of Chief Minister YS Jagan Mohan Reddy has approved investments of Rs 81,000 crores in green energy sector besides others to give a fillip to industrialisation in the State. The Chief Minister said that green energy would change the face of the economy of the State which
Uniindia: Vijayawada, Sep 5 (UNI) The State Investment Promotion Board (SIPB) meeting held here on Monday under the Chairmanship of Chief Minister YS Jagan Mohan Reddy has approved investments of Rs 81,000 crores in green energy sector besides others to give a fillip to industrialisation in the State.
At meeting held on 27 February 2021The Board of Aurobindo Pharma at its meeting held on 27 February 2021 has approved the following - 1. Transfer of all equity shares held in Lyfius Pharma, a wholly owned subsidiary of the Company, to Aurobindo Antibiotics, another wholly owned subsidiary of the Company. 2. Transfer of all equity shares held in Qule Pharma, a wholly owned subsidiary of the Company, to Aurobindo Antibiotics, another wholly owned subsidiary of the Company. 3. Transfer of business undertaking comprised in Unit-10, on a going concern basis, to APL Healthcare, a wholly owned s...
Shares of Aurobindo Pharma rose 5 per cent to Rs 966 in intra-day trade on the BSE on Monday, thus gaining 7 per cent in the past two trading days, on report that the government has given the company approval under the Production Linked Incentive (PLI) scheme for promotion of domestic manufacturing of critical bulk drugs. The PLI scheme aims at promotion of manufacturing of critical key starting materials (KSMs)/drug intermediates and APIs in the country. According to a report by Press Trust of India, Aurobindo Pharma (through Lyfius Pharma) received government approval for setting up plants...
The government has given approval to drug firms includingAurobindo Pharma and Karnataka Antibiotics & Pharmaceuticals under the PLI scheme for promotion of domestic manufacturing of critical bulk drugs. The Production Linked Incentive (PLI) scheme aims at promotion of manufacturing of critical key starting materials (KSMs)/drug intermediates and APIs in the country. The setting up of plants under the scheme will lead to total committed investment of Rs 3,761 crore by the companies and employment generation for around 3,825 people,the Ministry of Chemicals and Fertilizers said in a statemen...